April 27, 2010
The Department of Justice announced that AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA). Such unapproved uses are also known as "off-label" uses because they are not included in the drug’s FDA approved product label.
Press Release: Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing
Speech: Attorney General Eric Holder Speaks at the AstraZeneca Settlement Announcement
Website: justice.gov/civil